Interim report for the six months ended June 30, 2007

Summary: For the first six months of 2007 the Pharmexa Group generated revenues
and other operating income of DKK 10,774 thousand and a net loss of DKK 92,954
thousand. Research and development costs totalled DKK 89,608 thousand. The
Pharmexa Group expects a net loss for 2007 of DKK 190 million against
previously expected DKK 185 million.